Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats

Neuroscience

Volumn 202, Issue , 2012, Pages 69-76

  Sherin, A ^a   Anu, J ^a   Peeyush, K T ^a   Smijin, S ^a   Anitha, M ^a   Roshni, B T ^a   Paulose, C S ^a  

^a Department of Physics   (India)

Author keywords

Cholinergic receptor; Diabetes; GABA; Hippocampus; Hypoglycemia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; GLUTAMATE DECARBOXYLASE; MUSCARINIC M3 RECEPTOR; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOWN REGULATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOGLYCEMIA; MALE; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; STREPTOZOCIN DIABETES; UPREGULATION;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD GLUCOSE; CHOLINE O-ACETYLTRANSFERASE; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; NERVE TISSUE PROTEINS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; RECEPTORS, CHOLINERGIC; RECEPTORS, GABA; RECEPTORS, GABA-A; RECEPTORS, GABA-B; RECEPTORS, NICOTINIC;

EID: 84856214592     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.058     Document Type: Article

References (59)

1. Abdelmalik P.A., Shannon P., Yiu A., Liang P., Adamchik Y., Weisspapir M., Samoilova M., Burnham W.M., Carlen P.L. Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction. Neurobiol Dis 2007, 26:646-660.
2. Acsády L., Kamondi A., Sík A., Freund T., Buzsáki G. GABAergic cells are the major postsynaptic targets of mossy fibers in the rat hippocampus. J Neurosci 1998, 18:3386-3403.
3. Alkondon M., Pereira E.F.R., Eisenberg H.M., Albuquerque E.X. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 1999, 19:2693-2705.
4. Alvarez E.O., Beauquis J., Revsin Y., Banzan A.M., Roig P., De Nicola A.F., Saravia F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2009, 198:224-230.
5. Arison R.N., Ciaccio E.I., Glitzer M.S., Cassaro J.A., Pruss M.P. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes 1967, 16:51-56.
6. Auer R.N. Hypoglycaemic brain damage. Forensic Sci Int 2004, 146:105-110.
7. Bitner R.S., Bunnelle W.H., Anderson D.J., Briggs C.A., Buccafusco J., Curzon P., Decker M.W., Frost J.M., Gronlien J.H., Gubbins E., Li J., Malysz J., Markosyan S., Marsh K., Meyer M.D., Nikkel A.L., Radek R.J., Robb H.M., Timmermann D., Sullivan J.P., Gopalakrishnan M. Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways. J Neurosci 2007, 27:10578-10587.
8. Boess F.G., De Vry J., Erb C., Flessner T., Hendrix M., Luithle J., Methfessel C., Riedl B., Schnizler K., van der Staay F.J., van Kampen M., Wiese W.B., Koenig G. The novel alpha7 nicotinic acetylcholine receptor agonist N- [(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-arboxamide improves working and recognition memory in rodents. J Pharmacol Exp Ther 2007, 321:716-725.
9. Casasola C., Bargas J., Arias-Montaño C.E., Montiel T., Galarraga E., Brailowsky S. Hippocampal hyperexcitability induced by GABA withdrawal is due to down-regulation of GABAA receptors. Epilepsy Res 2002, 47:257-271.
10. Clarke P.B., Schwartz R.D., Paul S.M., Pert C.B., Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci 1985, 5:1307-1315.
11. Dalrymple-Alford J.C. Behavioral effects of basal forebrain grafts after dorsal septo-hippocampal pathway lesions. Brain Res 1994, 661:243-258.
12. Denise T., Tom O.V., Philip E.C., William J.P. Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci U S A 2004, 101:6217-6221.
13. Durkin T.P. GABAergic mediation of indirect transsynaptic control over basal and spatial memory testing-induced activation of septo-hippocampal cholinergic activity in mice. Behav Brain Res 1992, 50:155-165.
14. Flanagan D.E., Evans M.L., Monsod T.P., Rife F. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 2003, 284:313-316.
15. Gao B., Hornung J.P., Fritschy J.M. Identification of distinct GABAA-receptor subtypes in cholinergic and parvalbumin-positive neurons of the rat and marmoset medial septum-diagonal band complex. Neuroscience 1995, 65:101-117.
16. Ghajar J.B., Gibson G.E., Duffy T.E. Regional acetylcholine metabolism in brain during acute hypoglycemia and recovery. J Neurochem 1985, 44:94-98.
17. Ghareeb D.A., Hussen H.M. Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats. Neurosci Lett 2008, 436:44-47.
18. Gireesh G., Kaimal S.B., Kumar T.P., Paulose C.S. Decreased muscarinic M1 receptor gene expression in the hypothalamus, brainstem, and pancreatic islets of streptozotocin-induced diabetic rats. J Neurosci Res 2008, 86:947-953.
19. Haces M.L., Montiel T., Massieu L. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 2010, 165:28-38.
20. Hashimoto K., Ishima T., Fujita Y., Matsuo M., Kobashi T., Takahagi M., Tsukada H., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Biol Psychiatry 2008, 63:92-97.
21. Hefco V., Yamada K., Hefco A., Hritcu L., Tiron A., Olariu A., Nabeshima T. Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats. Eur J Pharmacol 2003, 474:227-232.
22. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 1980, 13:453-456.
23. Hertz L., Dienel G. Energy metabolism in the brain. Glucose metabolism in the brain 2002, 2-102. Academic Press, San Diego. D. Dwyer (Ed.).
24. Hohenegger M., Rudas B. Kidney function in experimental diabetic ketosis. Diabetologia 1971, 7:334-338.
25. Hyde T.M., Crook J.M. Cholinergic systems and schizophrenia: primary pathology or epiphenomena?. J Chem Neuroanat 2001, 22:53-63.
26. Izquierdo I., Medina J.H. Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 1995, 63:19-32.
27. Jean-Marc F. Epilepsy, E/I balance and GABAA receptor plasticity. Front Mol Neurocsi 2008, 1:5.
28. Joseph A., Remya R., Paulose C.S. Enhanced [3H] glutamate binding in the cerebellum of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Cell Mol Neurobiol 2007, 27:1085-1095.
29. Joseph A., Sherin A., Paulose C.S. Increased glutamate receptor gene expression in the cerebral cortex of insulin induced hypoglycaemic and streptozotocin induced diabetic rats. Neuroscience 2008, 156:298-304.
30. Kiss J., Patel A.J., Baimbridge K.G., Freund T.F. Topographical localization of neurons containing parvalbumin and choline acetyltransferase in the medial septum-diagonal band region of the rat. Neuroscience 1990, 36:61-72.
31. Kuhad A., Pilkhwal S., Sharma S., Tirkey N., Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J Agric Food Chem 2007, 55:10150-10155.
32. Kurioka S., Kimura Y., Matsuda M. Effect of sodium and bicarbonate ions on GABA receptor binding in synaptic membrane of rat brain. J Neurochem 1981, 37:418-421.
33. Langan S.J., Deary I.J., Hepburn D.A., Frier B.M. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 1991, 34:337-344.
34. Levey A.I. Immunological localization of M1-M5 muscarinic acetylcholine receptors in peripheral tissue and brain. Life Sciences 1993, 52:441-448.
35. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., Heilman C.J. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J Neurosci 1995, 15:4077-4092.
36. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
37. Martin D.L., Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 1993, 60:395-407.
38. Messier C., Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 1996, 75:1-11.
39. Paulsen R.E., Fonnum F.J. Regulation of transmitter y-aminobutyric acid (GABA). Synthesis and metabolism illustrated by the effect of y-vinyl GABA and hypoglycemia. J Neurochem 1988, 50:4.
40. Pichat P., Bergis O.E., Terranova J.P., Urani A., Duarte C., Santucci V., Gueudet C., Voltz C., Steinberg R., Stemmelin J., Oury-Donat F., Avenet P., Griebel G., Scatton B. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 2007, 32:17-34.
41. Poulin B., Butcher A., McWilliams P., Julie-Myrtille B., Robert P., Kok C.K., Bottrill A., Sharad M., Wess J., Elizabeth M.R., Steven J.C., Andrew B.T. The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner 2010, 10.1073/pnas.0914801107.
42. Prut L., Prenosil G., Willadt S., Vogt K., Fritschy J.M., Crestani F. A reduction in hippocampal GABAA receptor alpha5 subunits disrupts the memory for location of objects in mice. Genes Brain Behav 2010, 9:478-488.
43. Chang B.S., Lowenstein D.H. Epilepsy. N Engl J Med 2003, 349:1257-1266.
44. Robinson R., Krishnakumar A., Paulose C.S. Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats. Cell Mol Neurobiol 2009, 29:365-372.
45. Sanz B., Exposito I., Mora F. M1 acetylcholine receptor stimulation increases the extracellular concentrations of glutamate and GABA in the medial prefrontal cortex of the rat. Neurochem Res 1997, 22:281-286.
46. Sato A., Sato Y., Uchida S. Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Auton Neurosci 2002, 96:13-19.
47. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949, 51:660-672.
48. Soghomonian J.J., Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol Sci 1998, 19:500-555.
49. Soreq H., Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001, 2:294-302.
50. Steiger J.L., Russek S.J. GABAA receptors: building the bridge between subunit mRNAs, their promoters, and cognate transcription factors. Pharmacol Ther 2004, 101:259-281.
51. Suh B.C., Hille B. Regulation of ion channels by phosphatidylinositol 4, 5-bisphosphate. Curr Opin Neurobiol 2005, 15:370-378.
52. Suh S.W., Aoyama K., Chen Y., Garnier P., Matsumori Y., Gum E., Liu J., Swanson R.A. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 2003, 23:10681-10690.
53. Suh S.W., Gum E.T., Hamby A.M., Chan P.H., Swanson R.A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 2007, 117:910-918.
54. Tõugu V., Kesvatera T. Role of ionic interactions in cholinesterase catalysis. Biochim Biophys Acta 1996, 1298:12-30.
55. Tucek S. Acetylcoenzyme A and the synthesis of acetylcholine in neurones: review of recent progress. Gen Physiol Biophys 1983, 2:313-324.
56. Van der Zee E.A., Buwalda B., Strubbe J.H., Strosberg A.D., Luiten P.G. Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas. Cell Tissue Res 1992, 269:99-106.
57. Wessels A.M., Scheltens P., Barkhof F., Heine R.J. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 2008, 585:88-96.
58. Yamamura H.I., Synder G. Binding of [3H] QNB in rat brain. Proc Natl Acad Sci U S A 1981, 71:1725-1729.
59. Yoshikawa H., Honma T., Abe T. Persistent hyperinsulinemic hypoglycaemia followed as benign infantile convulsion. Seizure 2003, 12:186-187.